Skip to main content

Injectable Contraceptive Assessment in Uganda and Nigeria

This webinar presented key findings from a two-phased research program funded by The Bill & Melinda Gates Foundation in Nigeria and Uganda. The first phase was a qualitative exploration within Focus Group discussions (total sample n=600 in 100 Focus Groups (n=6 per FG) across 8 different FG types and split across 2 urban and 2 rural settings per country) with women and their male partners (separately). The second phase was a quantitative survey with women (total sample n=1,410 women) split across 4 regions within each country.

The research explored several central topics:

  • The various contraceptive journeys and experiences of women and their male partners, including satisfied and discontinued users of the injectable contraceptive (Depo), satisfied users of the DMPA-SC (Sayana Press), na├»ve users of modern contraceptive and those using traditional methods.
  • Factors which lead to discontinuation and experiences with/perception of side effects.
  • Gauged level of acceptability and preference for certain injectable attributes, in particular the impact of DMPA-SC 3 months or a potential 6 month injectable on likelihood to try. We tested 3 fully developed concepts and vary the most impactful features from phase 1 with women.
  • Developed a forecast model for Depo, DMPA-SC 3-month and a potential 6-month injectable in Nigeria and Uganda.

Institutional author(s): Reproductive Health Supplies Coalition (RHSC), Routes2Results
Publication date: November, 2019

  • Webinar recording